<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://cumulusoncology.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://cumulusoncology.com/bioworld-cumulus-raising-50m-spinning-gpr68-small-molecules-into-gio/</loc><lastmod>2025-09-12T07:50:35+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-and-leadxpro-achieve-critical-milestone-in-gpr68-drug-discovery-project/</loc><lastmod>2025-09-12T09:44:28+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-appoints-catherine-lewis-la-torre-to-its-board-of-directors/</loc><lastmod>2025-09-12T09:44:48+00:00</lastmod></url><url><loc>https://cumulusoncology.com/university-of-eastern-finland-uef-and-cumulus-oncology-announce-new-collaboration/</loc><lastmod>2025-09-12T09:44:55+00:00</lastmod></url><url><loc>https://cumulusoncology.com/launch-of-gio-therapeutics-founded-by-cumulus-oncology-to-develop-therapeutics-targeting-g-protein-coupled-receptors-to-treat-cancer-and-inflammation/</loc><lastmod>2025-09-12T09:45:05+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-raises-9m-in-seed-financing/</loc><lastmod>2025-09-12T09:45:14+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-and-leadxpro-announce-collaboration-to-develop-small-molecules-against-novel-cancer-focused-gpcr-targets/</loc><lastmod>2025-09-12T09:45:23+00:00</lastmod></url><url><loc>https://cumulusoncology.com/nodus-oncology-secures-2-4m-2-9m-investment/</loc><lastmod>2025-09-07T19:48:42+00:00</lastmod></url><url><loc>https://cumulusoncology.com/nodus-oncology-announces-acquisition-of-basilea-pharmaceuticas-parg-inhibitor-programme/</loc><lastmod>2025-09-07T19:50:57+00:00</lastmod></url><url><loc>https://cumulusoncology.com/edinburgh-cancer-discovery-accelerator-cumulus-hires-chief-scientific-officer-with-invaluable-skills/</loc><lastmod>2025-09-07T19:52:07+00:00</lastmod></url><url><loc>https://cumulusoncology.com/nodus-oncology-launches-founded-by-cumulus-oncology-and-in-partnership-with-the-lead-discovery-center-to-focus-on-developing-first-and-best-in-class-molecules-inhibiting-novel-dna-damage-response-ta/</loc><lastmod>2025-09-07T19:51:33+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-secures-4-1m-5-6m-investment-led-by-eos-advisory/</loc><lastmod>2025-09-07T19:53:16+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-appoints-edinburgh-uni-neuroscience-graduate-as-chief-operating-officer/</loc><lastmod>2025-09-07T19:55:21+00:00</lastmod></url><url><loc>https://cumulusoncology.com/ldc-and-cumulus-oncology-announce-collaboration/</loc><lastmod>2025-09-07T19:56:25+00:00</lastmod></url><url><loc>https://cumulusoncology.com/eos-backs-europes-first-oncology-drug-discovery-accelerator-cumulus/</loc><lastmod>2025-09-07T19:58:20+00:00</lastmod></url><url><loc>https://cumulusoncology.com/cumulus-oncology-strengthens-its-leadership-with-new-appointments-to-the-board-of-directors-and-scientific-advisory-team/</loc><lastmod>2025-09-16T10:08:58+00:00</lastmod></url><url><loc>https://cumulusoncology.com/bringing-patient-biology-into-early-drug-development-oncode-accelerator/</loc><lastmod>2026-05-05T14:37:20+00:00</lastmod></url></urlset>
